Распространенность и клиническое значение эректильной дисфункции у кардиологических больных
Диссертация
Большинство опрошенных не считает ЭД болезнью, связывая ее появление со стрессом и усталостью. Это приводит к неэффективному (а порой и небезопасному) самолечению и дальнейшему прогрессированию болезни. По данным опроса, проведенного Хамди Ф. К. и соавт. (1997), о возможности влияния лекарств на сексуальную функцию знают 64% мужчин в Испании, 51% — во Франции, 38% в Великобритании. В то же время… Читать ещё >
Список литературы
- Арабидзе Г. Г., Арабидзе Гр. Г. Антигипертензивная терапия и половая функция у мужчин. // Клиническая Фармакология и терапия -1999. -N3.- С. 49−52.
- Верткин A.JI. Эректильная дисфункция в практике врача-кардиолога. // В сборнике «Эректильная дисфункция, диагностика и лечение». М.: Практика, 2004, С. 82 96.
- Верткин А.Д., Лоран О. Б., Тополянский A.B., Носовицкий П. Б., Жиленко В. В. Эректильная дисфункция у кардиологических и терапевтических пациентов. // Русский медицинский журнал. 2002. — Том 10. -№ 28-С.32−36.
- Калинченко С.Ю. Новые подходы в лечении эректильной дисфункции у больных сахарным диабетом. //М.: Практика, 2004. С. 70 -81.
- Кротовский Г. С., Зудин A.M. Виагра 5 лет успеха. — М. — 2003.- 189 с.
- Лу. Т. Нарушения половой функции у мужчин. // Глава 47 из книги «Урология по Дональду Смиту». М.: Практика, 2004. 430с.
- Мак-Вари К. Эректильная дисфункция. Глава 51 из книги «Внутренние болезни по Тинсли Р. Харрисону», 15-е издание. // В сб. Эректильная дисфункция, диагностика и лечение. М.: Практика, 2004. — С. 46 60.
- Хамди Ф.К., Карретеро П., Перрен П. Влияние возраста, заболеваний и приема лекарств на сексуальную активность мужчин в странах Европы. // Медицинские новости. 1997. — N 2. — С. 659 — 670.
- Щеплёв П.А., Вёрткин A.JL, Тополянский А. В., Жиленко В. В., Носовицкий П. Б. Эректильная дисфункция у кардиологических пациентов. // Лечащий врач. 2002. — № 3 — С. 21 — 24.
- Щеплёв П.А., Тополянский А. В., Жиленко В. В., Носовицкий П. Б. Эректильная дисфункция и сердечно-сосудистые заболевания. // Медицинская кафедра. 2002 — № 2. — С. 7 — 11.
- Aranda P., Ruilope L.M., Calvo С., Luque М., Coca A., Gil de Miguel A. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. // Am. J. Hypertens. 2004. -Vol. 17.-N2.-P. 139−145.
- Bacon C.G., Hu F.B., Giovannucci E., Glasser D.B., Mittleman M.A., Rimm E.B. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. // Diabetes Care. 2002. — Vol. 25. — N 8. -P. 1458- 1463.
- Badalyan R., Schultheiss D., Wasielevski von R., Jonas U., Stief C. Cigarette smoking as a risk factor in penile corpus cavernosum degeneration. // European Urology supplements. 2004. — Vol. 3. — N 2. — P. 6.
- Barrett-Connor E. Cardiovascular risk stratification and cardiovascular risk factors associated ith erectile dysfunction: assessing cardiovascular risk in men with erectile dysfunction. // Clin. Cardiol. 2004. -Vol. 27. — N 4 Suppl 1. — P. 18 — 13.
- Bauer G.E., Hunyor S.N., Baker J., et al. Side effects of antihypertensive treatment: a placebo-controlled study. // Clin. Sci Mol. Med. -1978. Vol. 55. — P. 341S — 344S.
- Bedell S.E., Duperval M., Goldberg R. Cardiologists' discussions about sexuality with patients with chronic coronary artery disease. // Am. Heart. J. 2002. — Vol. 144. — N 2. — P. 239 — 242.
- Blumentals W.A., Gomez-Caminero A., Joo S., Vannappagari V. Is erectile dysfunction predictive of peripheral vascular disease? // Aging Male. -2003. Vol. 6. — N 4. — P. 217 — 221.
- Braun M., Sommer F., Lehmacher W., Raible A., Bondarenko B., Engelmann U. Erectile dysfunction. Are interdisciplinary diagnosis and therapy necessary? // Dtsch. Med. Wochenschr. 2004. — Vol. 29. — N 4. -P 131 — 136.
- Braun M., Wassmer G., Klotz T., Reifenrath B., Mathers M., Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey. // Int J Impot. Res. 2000. — Vol. 12. — N 6. — P. 305 — 311.
- Bruckert E., Giral P., Heshmati H.M., Turpin G. Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction. // J Clin Pharm. Ther. 1996. — Vol. 21. — N 2. — P. 89 — 94.
- Bulpitt C.J., Dollery C.T. Side effects of hypotensive agents evaluated by a self-administered questionnaire. // Br Med J. 1973. — Vol. 3. — N5878.-P. 485−490.
- Bulpitt C.J., Dollery C.T., Carne S. Changes in symptoms in hypertensive patients after referral to hospital clinic. // Br. Heart J. — 1976. — Vol. 38.-N2.-P. 121−128.
- Burchardt M., Burchardt T., Baer L., et al. Hypertension is associated with severe erectile dysfunction. // J. Urol. 2000. — Vol. 164. — N 4.-P. 1188−1191.
- Burt V.L., Whelton P., Rocella E. et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey. // Hypertension. 1995. — Vol. 25. — N 3. — P. 305−313.
- Caro J., Vidal J., Vicente J. et al. Sexual dysfunction in hypertensive patients treated with losartan. // J. Med. Sci. 2001. — Vol. 321. -P. 336−341.
- Carson C.C. Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education. // Int. J. Impot. Res. -2002. Vol. 14. — Suppl 1. — S29 — S34.
- Cellek S., Rodrigo J., Lobos E. et al. Selective nitrergic neurodegeneration in diabetes mellitus a nitric oxide-dependent phenomenon. // Br. J. Pharmacol. — 1999. — Vol. 128. -N 8. — P. 1804 — 1812.
- Chang S.W., Fine R., Siegel D. et al. The impact of diuretic therapy on reported sexual function. // Arch. Intern. Med. 1991. — Vol. 151. -N 12.-P. 2402−2408.
- Chew K.K., Earle C.M., Stuckey B.G., Jamrozik K., Keogh E.J. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. // Int. J. Impot. Res. 2000. — Vol. 12. — N 1. — P. 41 — 45.
- Chu N.V., Edelman S.V. Erectile dysfunction and diabetes. // Curr. Diab. Rep. 2002. — Vol. 2. — N 1. — P. 60 — 66.
- Costa P., Avances C., Wagner L. Erectile dysfunction: knowledge, wishes and attitudes. Results of a French study of 5.099 men aged 17 to 70. // Prog. Urol., 2003. Vol. 13, N 1. — P. 85 — 91.
- Croog S.H., Levine S., Sudilovsky A., et al. Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications. // Arch. Intern. Med. 1988.-Vol. 148.-N4.-P. 788−794.
- Croog S.H., Levine S., Testa M.A., et al. The effects of antihypertensive therapy on the quality of life. // N. Engl. J. Med. 1986. — Vol. 314. — N 26. — P. 1657 — 1664.
- Cuellar de Leon A.J., Ruiz Garcia V., Campos Gonzalez J.C., Perez Hoyos S., Brotons Multo F. Prevalence erectile dysfunction in patients with hypertension. // Med. Clin. (Bare.) 2002. — Vol. 119. — N 14. — P. 521 -526.
- Curb J.D., Borhani N.O., Blaszkowski T.P., et al. Long-term surveillance for adverse effects of antihypertensive drugs. // JAMA. 1985. -Vol. 253. — N 22. — P. 3263 — 3268.
- Derby C.A., Barbour M.M., Hume A.L., McKinlay J.B. Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort // Pharmacotherapy. 2001. — Vol. 21. — N 6. — P. 676 -683.
- Dorrance A.M., Lewis R.W., Mills T.M. Captopril treatment reverses erectile dysfunction in male Stroke Prone Spontaneously Hypertensive Rat. // Int. J. Impot. Res. 2002. — Vol. 14. — N 6. — P. 494 — 497.
- Fedele D., Coscelli C., Cucinotta D, et al. Incidence of erectile dysfunction in Italian men with diabethes. // J. Urology. 2001. -Vol. 166. — N 4.-P. 1368−71.
- Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., McKinlay J.B. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. // J. Urolology. 1994. — Vol. 151. -P. 151 — 154.
- Ferrario C.M., Levy P. Sexual dysfunction in patients with hypertension: implications for therapy. // J. Clin. Hypertens. (Greenwich). -2002. Vol. 4. — N 6. — P. 424 — 432.
- Flack J.M., Novikov S.V., Ferrario C.M. Benefits of adherence to anti-hypertensive drug therapy. // Eur. Heart J. 1996. — Vol. 17. — Suppl A. -P. 16−20.
- Fogari R., Corradi I., Poletti L. et al. Sexual activity in hypertensive males treated with valsartan or Carvedilol. A cross-over study // J. of Hypertension. 1999. — Vol. 17. — Suppl. 3. — S. 65.
- Fogari R., Zoppi A. Effects of antihypertensive therapy on sexual activity in hypertensive men. // Curr. Hypertens. Rep. 2002. — Vol. 4. — N 3. -P. 202−210.
- Fogari R., Zoppi A., Corradi L., et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. //. Am. J. Hypertens. 1998. — Vol. 11. — N 10. — P. 1244 — 1247.
- Fogari R., Zoppi A., Poletti L. et al. Sexual activity in hypertensive men treated with valsartan or Carvedilol: a crossover study. // Am. J. Hypertens. 2001. — Vol. 14. — N 1. — P. 27 — 31.
- Foresta C., Caretta N., Aversa A., Bettocchi C., Corona G., Mariani S., Rossato M. Erectile dysfunction: symptom or disease? // J. Endocrinol. Invest. 2004. — Vol. 27. -N 1. — P. 80 — 95.
- Fung M.M., Bettencourt R., Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. //J. Am. Coll. Cardiol. -2004.-Vol. 43.-N8.-P. 1405- 1411.
- Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. // Am. J. Cardiol. -2000.-Vol. 86.-N2A.-41F-45 °F.
- Greenstein A., Chen J., Miller H., Matzkin H., Villa Y., Braf Z. Does severity of ischemic coronary disease correlate with erectile function? // Int. J. Impot. Res. 1997. — Vol. 9. -N 3. — P. 123 — 126.
- Guay A.T. Sexual dysfunction in the diabetic patient. // Int. J. Impot. Res. 2001. — Vol. 13. — Suppl 5. — S. 47 — 50.
- Hale T.M., Okabe H., Bushfield T.L., Heaton J.P., Adams M.A. Recovery of erectile function after brief aggressive antihypertensive therapy. // J. Urol.-2002.-Vol. 168. -N 1.-P. 348−354.
- Hogan M J., Wallin J.D., Baer R.M. Antihypertensive therapy and male sexual dysfunction. // Psychosomatics. 1980. — Vol. 21. — P. 234−237.
- Hood S., Robertson I. Erectile dysfunction: a significant health need in patients with coronary heart disease. // Scott. Med. J. 2004. — Vol. 49 -N3.-P. 97−98.
- Hutter A.M. Jr. Role of the cardiologist: clinical aspects of managing erectile dysfunction. // Clin Cardiol. 2004. — Vol. 27. — N 4, Suppl 1.-P. 13−17.
- Jackson G. Sexual dysfunction and diabetes. // Int J Clin Pract. -2004. Vol. 58. — N 4. — P. 358 — 362.
- Jackson G., Giuilano F. Moderator’s introduction // Eur. Heart. J. Suppl. 2002. — Vol. 4. — Suppl. H. — P. 1 — 6.
- Jaffe A., Chen Y., Kisch E.S., Fischel B., Alon M., Stem N. Erectile dysfunction in hypertensive subjects. Assessment of potential determinants. // Hypertension. 1996. — Vol. 28, N 5. — P. 859 — 862.
- J.C. Cappelleri, R.C. Rosen, M.D. Smith, A.M. Misra, I.H. Osterlon. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Dysfunction. // J. Urology 1999. — Vol. 54. -P. 346−351.
- Kaiser D.R., Billups K., Mason C., Wetterling R., et al. // J. Am. Col. Card. 2004. — Vol. 43. -N 2. — P. 179 — 184.
- Kawanishi Y., Kimura K., Nakanishi R., Numata A., Taguchi H. Retinal vascular findings and penile cavernosal artery blood flow. // BJU Int. -2003. Vol. 92. — N 9. — N 977 — 980.
- Kawanishi Y., Lee K.S., Kimura K. et al. Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients.//Int. J. Impot. Res. 2001.-Vol. 13-N 2.-H. 100 — 103.
- Kimmel SE. Sex and myocardial infarction: an epidemiologic perspective. // Am J Cardiol. 2000, 86(2A):10 °F — 13 °F.
- Khan M.A., Morgan R.J., Mikhailidis D.P. The choice of antihypertensive drugs in patients with erectile dysfunction. // Curr. Med. Res. Opin. 2002. — Vol. 18.-N 2.-P. 103- 107.
- Kim S.W., Paick J., Park D.W., Chae I., Oh B. Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction. // Urology. 2001. — Vol. 58. — N 3. — P. 441 — 445.
- Kirby M., Jackson G., Betteridge J., Friedli K. Is erectile dysfunction a marker for cardiovascular disease? // Int. J. Clin. Pract. 2001. -Vol. 55.-N9.-P. 614−618.
- Kloner R.A. Erectile dysfunction in the cardiac patient. // Compr Ther. 2004. — Vol. 30. -N 1. — P. 50 — 54.
- Ko D.T., Hebert P.R., Coffey C.S., Sedrakyan A., Curtis J.P., Krumholz H.M. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. // JAMA. 2002. — Vol. 288. — N 3. — P. 351 — 357.
- Kogan M.I., Sizijakin D.V., Terentiev V.P. Erectil dysfunction as a figure of life merit in patients with essential hypertension // The 3rd World Congress of the aging male. // Munich, 2000: Abstracts 53. P. 229.
- Kung C.F., Luscher T.F. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. // Hypertension. 1995. — Vol. 25. — N 2. — P. 194 — 200.
- Kuritzky L. Counseling the patient with erectile dysfunction: a primary care physician perspective. // J. Am. Osteopath. Assoc. 2002. — Vol. 102. -N 12, Suppl 4. — S7 — 11.
- Laumann E.O., Paik A., Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. // JAMA. 1999. — Vol. 281. — N 6. -P. 537 — 544.
- Leiblum S.R., Baume R.M., Croog S.H. The sexual functioning of elderly hypertensive women. // J. Sex Marital. Ther. 1994. — Vol. 20. — P. 250 -270.
- Li J.S., Sharifi A.M., Schiffrin E.L. Effect of AT, angiotensin-receptor blockade on structure and function of small arteries in SHR. // J. Cardiovasc. Pharmacol. 1997. — Vol. 30. — N 1. — P. 75 — 83.
- Llisteri J.L., Vidal J.V.L., Aznar Vincente J.A. et al. Sexual dysfunction in hypertensive patients treated with losartan. // Am. J. Med. Sci. -2001.-Vol. 321.-N 5.-P. 336−341.
- Marley J.E. Safety and efficacy of nifedipine 20 mg tablets in hypertension using electronic data collection in general practice. // J. R. Soc. Med. 1989. — Vol. 82. — N 5. — P. 272 — 275.
- Marwick C. Survey says patients expect little physician help on Sex. // JAMA. 1999. — Vol. 281. — N 23. — P. 2173 — 2174.
- McCulloch D.K., Campbell I.W., Wy F.C. et al. The prevalence of diabetic impotence. // Diabetologia. 1980. — Vol. 18. — P. 279.
- Metro M.J., Broderick G.A. Diabetes and vascular impotence: does insulin dependence increase the relative severity? // Int. J. Impot. Res. 1999. -Vol. 11.-N2.-P. 87−89.
- Meuleman E.J., Donkers L.H., Robertson C., Keech M., Boyle P., Kiemeney L.A. Erectile dysfunction: prevalence and effect on the quality of life- Boxmeer study. // Ned Tijdschr Geneeskd. 2001. — Vol. 145. — N 12. -P. 576−581.
- Mickley H. Incidence and treatment of sexual dysfunction in heart disease. Ugeskr Laeger. // 2002. Vol. 164. — N 41. — P. 4760 — 4764.
- Mirone V., Ricci E., Gentile V., Basile Fasolo C., Parazzini F. Determinants of erectile dysfunction risk in a large series of Italian menattending andrology clinics. // European Urology. 2004. — Vol. 45. — N 1. — P. 87−91.
- Muller J.E. Triggering of cardiac events by sexual activity: findings from a case-crossover analysis. // Am. J. Cardiol. 2000. — Vol. 86. P. 14 °F.
- Nelson E.C., Stason W.B., Neutra R.R., Solomon H.S. Identification of the noncompliant hypertensive patient. // Prev Med. 1980. -Vol. 9.-N4.-P. 504−517.
- Nusbaum M.R. Erectile dysfunction: prevalence, etiology, and major risk factors. // J. Am. Osteopath. Assoc. 2002. — Vol. 102. — N 12, Suppl 4. — SI — 6.
- CTKane P.D., Jackson G. Erectile dysfunction, is there silent obstructive coronary artery disease? // Int. J. Clin. Prac. 2001. — Vol. 55. — P. 219−220.
- Okabe H., Hale T.M., Kumon H., Heaton J.P., Adams M.A. The penis is not protected: in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. // Int. J. Impot. Res. — 1999. — Vol. 11.-N3.-P. 133 140.
- O’Keefe M., Hunt D.K. Assessment and treatment of impotence. // Med. Clin. N. Am. 1995. — Vol. 79 — N 2. — P. 415 — 434.
- Palmore E.B. Predictors of the longevity difference: a 25-yea follow-up. // Gerontologist. 1982. — Vol. 22. — N 6. — P. 513 — 518.
- Persson G. Five-year mortality in a 70-year-old urban populatiol in relation to psychiatric diagnosis, personality, sexuality am early parental death. // Acta Psychiatr. Scand. 1981. — Vol. 64. — N 3. — P. 244 — 253.
- Prins J et al. prevalence of erectile dysfunctions: a systematic review of population-based studies. // Int J Impot Res. 2003 — Vol. 14. — P. 422−432.
- Prisant L.M., Carr A.A., Bottini P.B. et al. Sexual dysfunction with antihypertensive drugs. // Arch. Intern. Med. 1994. — Vol. 154. — N 7. — P. 730−736.
- Ralph D., McNicholas T. UK management guidelines for erectile dysfunction. // BMJ. 2000. — Vol. 321. — N 19. — P. 499 — 503.
- Riley A.J., Steiner J.A., Cooper R. et al. The prevalence of sexual dysfunction in male and female hypertensive patients. // Sex Marital. Ther. -1967.-Vol. 2.-P. 131−138.
- Romeo J.H., Seftel A.D., Madhun Z.T., Aron D.C. Sexual function in men with diabetes type 2: association with glycemic control // J. Urol. -2000.-Vol. 163.-N3.-P. 788−791.
- Rosen RC. Sexual dysfunction as an obstacle to compliance with antihypertensive therapy. // Blood Press Suppl. 1997. — Vol. 1. — P. 47 — 51.
- Roumeguere T., Wespes E., Carpentier Y., Hoffmann P., Schulman C.C. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. // Eur. Urol. 2003. — Vol. 44. -N 3. — P. 355 — 359.
- Sairam K., Kulinskaya E., Boustead G.B., Hanbury D.C., McNicholas T.A. Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction.//BJU Int.-2001.-Vol. 88.-N 1.-P. 68 71.
- ScharfM.B., Mayleben D.W. Comparative effects of prazosin and hydrochlorothiazide on sexual function in hypertensive men. // Am. J. Med. -1989.-Vol. 86.-N IB.-P. 110−112.
- Seftel A.D., Sun P., Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction // J Urol. 2004. — Vol. 171. — N 6 Pt 1. — P. 2341 — 2345.
- Smith D. G., Frankel S., Yamell J. Sex and death: are they related? Findings from the Caerphilly Cohort Study. // BMJ. 1997. — Vol. 315. — N 7123.-P. 1641 — 1644.
- Solomon H., Man J., Wierzbicki A.S., O’Brien T., Jackson G. Erectile dysfunction: cardiovascular risk and the role of the cardiologist. // Int. J. Clin. Pract. 2003. — Vol. 57. — N 2. — P. 96−99.
- Solomon H., Man J.W., Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. // Heart. 2003. — Vol. 89. — N 3. — P. 251 — 253.
- Speel T.G., van Langen H., Meuleman E.J. The risk of coronary heart disease in men with erectile dysfunction. // Eur. Urol. — 2003. — Vol. 44. — N3.-P. 366−371.
- Swanson-Fisher R.W., Clover K. Compliance in the treatment of hypertension. A need for action. // Am. J. Hypertens. 1995. — Vol. 8. — N 10 Pt 2. — P. 82S — 88S.
- Taddei S., Virdis A., Ghiadoni L., Magagna A., Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. // Hypertension. 1997. — Vol. 29. — N 1 Pt 2. — P. 274 — 279.
- Toblli J.E., Stella I., Inserra F., Ferder L., Zeller F., Mazza O.N. Morphological changes in cavernous tissue in spontaneously hypertensive rats. //Am. J. Hypertens. 2000. — Vol. 13. — N 6, Pt 1. — P. 686 — 692.
- Van Bortel L.M., Struijker-Boudier H.A., Safar M.E. Pulse pressure, arterial stiffness, and drug treatment of hypertension. // Hypertension. 2001. — Vol. 38. — N 4. — P. 914 — 921.
- Vernet D., Cai L., Garban H., Babbitt M.L., Murray F.T. et al.: Reduction of penile nitric oxide synthase in diabetic BB/WOR (type 1) and BBZ/WOR (type 2) rats with erectile dysfunction. // Endocrinology. 1995. -Vol. 136.-P. 5709−5717.
- Walczak M.K., Lokhandwala N., Hodge M.B., Guay A.T. Prevalence of cardiovascular risk factors in erectile dysfunction. // J. Gend. Specif. Med. 2002. — Vol. 5. — N 6. — P. 19 — 24.
- Wassertheil-Smoller S., Blaufox M.D., Oberman A, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM Study. // Ann. Intern. Med. 1991. — Vol. 114. — N 8. — P. 613 — 620.
- Wei M., Macera C.A., Davis D.R., Hornung C.A., Nankin H.R., Blair S.N. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction // Am. J. Epidemiol. 1994. — Vol. 140.-N 10.-P. 930−937.
- Weinberger MH. Lowering blood pressure in patients without affecting quality of life. // Am. J. Med. 1989. — Vol. 86. — N IB. — P. 94 — 97.